GHRP-2 and GHRP-6 Stimulate Growth Hormone Release Through Multiple Signaling Pathways
GHRP-2 and GHRP-6 stimulate growth hormone release from pituitary tumor cells through protein kinase C signaling, with GHRP-2 being considerably more potent than GHRP-6.
Quick Facts
What This Study Found
GHRP-2 was considerably more potent than GHRP-6 at stimulating GH release through PKC-dependent pathways, and both caused crosstalk with the cAMP pathway in gsp oncogene-expressing tumors.
Key Numbers
How They Did This
Human pituitary somatotropinomas (with and without gsp oncogenes) were cultured and treated with GHRP-2 and GHRP-6. Phosphatidylinositol hydrolysis, cAMP production, and GH secretion were measured. PKC inhibition was used to confirm the signaling pathway.
Why This Research Matters
Understanding how GHRPs work at the cellular signaling level helps optimize their clinical use and explains why GHRP-2 may be more effective than GHRP-6.
The Bigger Picture
This study advanced understanding of how growth hormone-releasing peptides work at the molecular level, informing the development and clinical application of GH secretagogues.
What This Study Doesn't Tell Us
Study used human pituitary tumor cells, not normal pituitary tissue. Tumor cells may respond differently than healthy cells. In vitro conditions don't replicate in vivo complexity.
Questions This Raises
- ?Does GHRP-2's greater potency over GHRP-6 translate to better clinical outcomes?
- ?Could the PKC-cAMP pathway crosstalk be therapeutically exploited?
Trust & Context
- Key Stat:
- GHRP-2 more potent than GHRP-6 GHRP-2 was considerably more potent at stimulating both phosphatidylinositol hydrolysis and GH secretion from pituitary tumor cells
- Evidence Grade:
- Moderate in vitro evidence using human pituitary tumor tissue. Provides mechanistic insight but uses tumor cells rather than normal tissue.
- Study Age:
- Published in 1996, this is an early mechanistic study on GHRPs. GHRP-2's greater potency has been confirmed in subsequent clinical studies.
- Original Title:
- Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.
- Published In:
- Molecular endocrinology (Baltimore, Md.), 10(4), 432-8 (1996)
- Authors:
- Adams, E F(2), Lei, T, Buchfelder, M(2), Bowers, C Y, Fahlbusch, R
- Database ID:
- RPEP-00352
Evidence Hierarchy
Frequently Asked Questions
What are GHRP-2 and GHRP-6?
Growth hormone-releasing peptides (GHRPs) are synthetic peptides that stimulate the pituitary gland to release growth hormone. GHRP-2 and GHRP-6 are among the most studied, with GHRP-2 being the more potent of the two.
Why does potency matter?
Greater potency means GHRP-2 achieves the same growth hormone release at lower doses than GHRP-6. This study showed this potency difference comes from GHRP-2's stronger activation of the PKC signaling pathway in pituitary cells.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00352APA
Adams, E F; Lei, T; Buchfelder, M; Bowers, C Y; Fahlbusch, R. (1996). Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.. Molecular endocrinology (Baltimore, Md.), 10(4), 432-8.
MLA
Adams, E F, et al. "Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.." Molecular endocrinology (Baltimore, 1996.
RethinkPeptides
RethinkPeptides Research Database. "Protein kinase C-dependent growth hormone releasing peptides..." RPEP-00352. Retrieved from https://rethinkpeptides.com/research/adams-1996-protein-kinase-cdependent-growth
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.